PL411858A1 - Immunoglobuliny do aglutynacji ludzkich erytrocytów, sposób ich otrzymywania oraz zastosowania - Google Patents

Immunoglobuliny do aglutynacji ludzkich erytrocytów, sposób ich otrzymywania oraz zastosowania

Info

Publication number
PL411858A1
PL411858A1 PL411858A PL41185815A PL411858A1 PL 411858 A1 PL411858 A1 PL 411858A1 PL 411858 A PL411858 A PL 411858A PL 41185815 A PL41185815 A PL 41185815A PL 411858 A1 PL411858 A1 PL 411858A1
Authority
PL
Poland
Prior art keywords
agglutination
immunoglobulins
obtaining
applications
human erythrocytes
Prior art date
Application number
PL411858A
Other languages
English (en)
Other versions
PL234376B1 (pl
Inventor
Tomasz Klaus
Monika Bzowska
Joanna Bereta
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL411858A priority Critical patent/PL234376B1/pl
Priority to PCT/IB2015/056716 priority patent/WO2016156940A1/en
Publication of PL411858A1 publication Critical patent/PL411858A1/pl
Publication of PL234376B1 publication Critical patent/PL234376B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/53—Hinge
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Ujawniono immunoglobuliny do aglutynacji ludzkich erytrocytów, zwłaszcza przeciwciało IgG3 zdolne do specyficznej aglutynacji erytrocytów, w szczególności określonej grupy krwi, sposób ich otrzymywania oraz zastosowania.
PL411858A 2015-04-03 2015-04-03 Immunoglobuliny do aglutynacji ludzkich erytrocytów, sposób ich otrzymywania oraz zastosowania PL234376B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL411858A PL234376B1 (pl) 2015-04-03 2015-04-03 Immunoglobuliny do aglutynacji ludzkich erytrocytów, sposób ich otrzymywania oraz zastosowania
PCT/IB2015/056716 WO2016156940A1 (en) 2015-04-03 2015-09-03 Immunoglobulins for human erythrocyte agglutination, production and application method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL411858A PL234376B1 (pl) 2015-04-03 2015-04-03 Immunoglobuliny do aglutynacji ludzkich erytrocytów, sposób ich otrzymywania oraz zastosowania

Publications (2)

Publication Number Publication Date
PL411858A1 true PL411858A1 (pl) 2016-10-10
PL234376B1 PL234376B1 (pl) 2020-02-28

Family

ID=54293279

Family Applications (1)

Application Number Title Priority Date Filing Date
PL411858A PL234376B1 (pl) 2015-04-03 2015-04-03 Immunoglobuliny do aglutynacji ludzkich erytrocytów, sposób ich otrzymywania oraz zastosowania

Country Status (2)

Country Link
PL (1) PL234376B1 (pl)
WO (1) WO2016156940A1 (pl)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665558A (en) * 1994-05-17 1997-09-09 Gamma Biologicals, Inc. Method and apparatus useful for detecting bloodgroup antigens and antibodies

Also Published As

Publication number Publication date
PL234376B1 (pl) 2020-02-28
WO2016156940A1 (en) 2016-10-06

Similar Documents

Publication Publication Date Title
CY1122804T1 (el) Μονοκλωνικα αντισωματα εναντι ανθρωπινου αντιγονου ωριμανσης β κυτταρων (βcμα)
MA43859A (fr) Anticorps monoclonaux humainisés immunostimulants dirigés contre l'interleukine -2 humaine, et leurs protéines de fusion
DOP2018000259A (es) Proteínas de unión biespecíficas que se unen a una proteína inmunomoduladora y a un antígeno tumoral
CY1123163T1 (el) Αντισωματα που δεσμευουν beta klotho επικρατεια 2 και μεθοδοι χρησης αυτων
PH12018501611A1 (en) Antigen binding proteins thant bind pd-l1
CL2017003261A1 (es) Factor xi anticuerpos y métodos de uso
EA201892294A1 (ru) Антитела и композиции против tim-3
BR112017021040A2 (pt) anticorpos dirigidos contra proteína mucina e imunoglobulina de célula t3 (tim-3)
CY1123672T1 (el) Μεθοδοι αγωγης μιας ταυπαθειας
EP3470427A4 (en) MONOCLONAL INTERLEUKIN-17A HUMAN ANTIBODIES, PREPARATION METHOD AND USE THEREOF
BR112016014022A2 (pt) anticorpos anti-cd3, ácido nucleico isolado, vetor, célula hospedeira, método de produção do anticorpo anti-cd3, imunoconjugado, composição, uso do anticorpo anti-cd3, métodos de tratamento, métodos de intensificação da função imune e kit
CR20160270A (es) ANTICUERPOS ANTI-TAU (pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN
ES2969235T3 (es) Anticuerpo monoclonal que antagoniza e inhibe la unión del antígeno PD-1 humano a su ligando, método de preparación del mismo y aplicación del mismo
DK3455261T3 (da) Anti-ror2-antistoffer, antistoffragmenter, immunkonjugater deraf og anvendelser deraf
DK3380122T3 (da) Anti-5t4 antistoffer og antistoflægemiddel konjugater
EP3418305A4 (en) METHODS OF EXPRESSION AND PREPARATION OF BIVALENT BISPECIFIC ANTIBODY HYBRID PROTEIN
BR112017015880A2 (pt) anticorpos, usos e métodos
EP3321284A4 (en) Monoclonal antibody of human procalcitonin, preparation method therefor, and application thereof
BR112018002382A8 (pt) Novos anticorpos anti-gvpi humano e usos dos mesmos
EA202190633A1 (ru) Лекарственные формы для применения в педиатрии, способы получения и применения
UY36262A (es) Anticuerpos anti proteína similar a angiopoyetina 4 y métodos de uso
TWI800483B (zh) 抗人類血紅素單株抗體或抗體套組、抗人類血紅素單株抗體固定化不可溶性載體粒子、及使用其等之測定試劑或測定方法
EP3375875A4 (en) SEPARATING AGENT FOR HUMAN SERUM-DERIVED IgG POLYCLONAL ANTIBODIES, AND METHOD FOR SEPARATING HUMAN SERUM-DERIVED IgG POLYCLONAL ANTIBODIES USING SAME
BR112016029935A2 (pt) ?anticorpos anti-brdu, complexo, formulação farmacêutica e uso de anticorpo?
AR098221A1 (es) Conjugados de anticuerpo anti-efna4-fármaco